MRSA
Supported pathogenMRSAMethicillin-resistant Staphylococcus aureus
Medicines already documented
Documented evidenceRegistered studies whose listed conditions mention “mrsa”, “methicillin-resistant”, “methicillin resistant”, “staphylococcus aureus”, “staph aureus”.
- Amikacin Sulfate1 registered study
- Aminocaproic Acid1 registered study
- Argatroban1 registered study
- Aztreonam1 registered study
- Bacitracin2 registered studies
- Cefazolin Sodium4 registered studies
- Cefepime Hydrochloride2 registered studies
- Cefoxitin Sodium1 registered study
- Ceftaroline Fosamil3 registered studies
- Cephalexin1 registered study
- Chloramphenicol1 registered study
- Chlorhexidine Gluconate2 registered studies
- Cidofovir1 registered study
- Cilastatin Sodium1 registered study
- Ciprofloxacin1 registered study
- Clarithromycin1 registered study
- Clindamycin Hydrochloride5 registered studies
- Clindamycin Phosphate1 registered study
Show all 46
- Cloxacillin Sodium11 registered studies
- Cysteine Hydrochloride1 registered study
- Daptomycin9 registered studies
- Dicloxacillin Sodium1 registered study
- Doxycycline1 registered study
- Ertapenem Sodium2 registered studies
- Erythromycin1 registered study
- Hexachlorophene2 registered studies
- Kanamycin Sulfate1 registered study
- Labetalol Hydrochloride1 registered study
- Lincomycin Hydrochloride4 registered studies
- Linezolid2 registered studies
- Methicillin Sodium24 registered studies
- Minocycline Hydrochloride1 registered study
- Molindone Hydrochloride1 registered study
- Mupirocin19 registered studies
- Nafcillin Sodium4 registered studies
- Oxacillin Sodium9 registered studies
- Pentobarbital1 registered study
- Retapamulin4 registered studies
- Rifabutin1 registered study
- Rifampin1 registered study
- Sodium Gluconate2 registered studies
- Sulfamethoxazole5 registered studies
- Triclosan2 registered studies
- Trovafloxacin Mesylate1 registered study
- Vancomycin2 registered studies
- Vecuronium Bromide1 registered study
Laboratory measurements against MRSA recorded in ChEMBL.
- Acetohydroxamic Acidmeasured active in 0 of 1 lab record
- Amdinocillinmeasured active in 0 of 1 lab record
- Amikacin Sulfatemeasured active in 1 of 1 lab record
- Amoxicillinmeasured active in 20 of 26 lab records
- Ampicillin Sodiummeasured active in 5 of 20 lab records
- Azithromycinmeasured active in 7 of 9 lab records
- Azlocillin Sodiummeasured active in 1 of 1 lab record
- Capreomycin Sulfatemeasured active in 0 of 1 lab record
- Carbenicillin Disodiummeasured active in 3 of 5 lab records
- Cefaclormeasured active in 10 of 15 lab records
- Cefdinirmeasured active in 2 of 2 lab records
- Cefotaxime Sodiummeasured active in 11 of 16 lab records
- Cefoxitin Sodiummeasured active in 5 of 10 lab records
- Cefprozilmeasured active in 2 of 2 lab records
- Ceftazidimemeasured active in 5 of 5 lab records
- Ceftriaxone Sodiummeasured active in 8 of 8 lab records
- Cefuroxime Sodiummeasured active in 6 of 6 lab records
- Cephalexinmeasured active in 4 of 7 lab records
Show all 74
- Cephalothin Sodiummeasured active in 4 of 4 lab records
- Cetyl Alcoholmeasured active in 0 of 1 lab record
- Chloramphenicolmeasured active in 0 of 3 lab records
- Chlorhexidine Gluconatemeasured active in 1 of 1 lab record
- Choline C-11measured active in 0 of 1 lab record
- Ciprofloxacinmeasured active in 118 of 130 lab records
- Clarithromycinmeasured active in 10 of 12 lab records
- Clavulanate Potassiummeasured active in 1 of 8 lab records
- Dactinomycinmeasured active in 1 of 1 lab record
- Dalbavancin Hydrochloridemeasured active in 1 of 1 lab record
- Dalfopristinmeasured active in 1 of 1 lab record
- Daunorubicin Citratemeasured active in 2 of 2 lab records
- Doxorubicin Hydrochloridemeasured active in 0 of 1 lab record
- Doxycyclinemeasured active in 1 of 1 lab record
- Enoxacinmeasured active in 9 of 9 lab records
- Erythromycinmeasured active in 17 of 25 lab records
- Ethacrynic Acidmeasured active in 0 of 1 lab record
- Gatifloxacinmeasured active in 3 of 3 lab records
- Gemifloxacin Mesylatemeasured active in 4 of 4 lab records
- Grepafloxacin Hydrochloridemeasured active in 2 of 2 lab records
- Hexachlorophenemeasured active in 6 of 6 lab records
- Imipenemmeasured active in 44 of 77 lab records
- Kanamycin Sulfatemeasured active in 1 of 11 lab records
- Levofloxacinmeasured active in 1 of 1 lab record
- Lincomycin Hydrochloridemeasured active in 2 of 3 lab records
- Linezolidmeasured active in 39 of 44 lab records
- Lomefloxacin Hydrochloridemeasured active in 3 of 3 lab records
- Meropenemmeasured active in 16 of 17 lab records
- Methicillin Sodiummeasured active in 8 of 26 lab records
- Metronidazolemeasured active in 0 of 1 lab record
- Mezlocillin Sodium Monohydratemeasured active in 2 of 5 lab records
- Minocycline Hydrochloridemeasured active in 4 of 4 lab records
- Mupirocinmeasured active in 6 of 10 lab records
- Nafcillin Sodiummeasured active in 4 of 7 lab records
- Nalidixic Acidmeasured active in 0 of 5 lab records
- Norfloxacinmeasured active in 45 of 47 lab records
- Ofloxacinmeasured active in 26 of 27 lab records
- Oritavancin Diphosphatemeasured active in 2 of 2 lab records
- Oxacillin Sodiummeasured active in 9 of 22 lab records
- Paromomycin Sulfatemeasured active in 1 of 1 lab record
- Penicillin G Sodiummeasured active in 6 of 10 lab records
- Penicillin Vmeasured active in 2 of 3 lab records
- Piperacillin Sodiummeasured active in 6 of 12 lab records
- Rifampinmeasured active in 3 of 3 lab records
- Rifamycin Sodiummeasured active in 2 of 2 lab records
- Sparfloxacinmeasured active in 5 of 5 lab records
- Streptomycin Sulfatemeasured active in 2 of 2 lab records
- Sulbactam Sodiummeasured active in 2 of 5 lab records
- Tazobactam Sodiummeasured active in 2 of 2 lab records
- Telithromycinmeasured active in 9 of 11 lab records
- Tetracycline Hydrochloridemeasured active in 2 of 2 lab records
- Tobramycinmeasured active in 3 of 10 lab records
- Triclosanmeasured active in 2 of 2 lab records
- Trimethoprimmeasured active in 7 of 8 lab records
- Trovafloxacin Mesylatemeasured active in 0 of 1 lab record
- Vancomycinmeasured active in 103 of 103 lab records
Other medicines to investigate
AI prediction · nothing measuredApproved medicines with AI-predicted activity ≥40% against MRSA that are not already antimicrobials, have no registered study for this condition and have no laboratory record against it. Each shows what it is already used for. They were surfaced computationally for further investigation and are not presented as established treatments for this condition.
MRSA has 671 repurposing candidates in all. 7 are already listed above, with a registered study for this condition or a laboratory record, so the other 664 are listed here.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- OlaparibExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 9 more69.2% AI-predicted activityagainst MRSA50+ registered studies
- Ganirelix AcetateExisting use: Female infertility, Positive regulation of ovulation, Reproductive Techniques, Assisted69.1% AI-predicted activityagainst MRSA50+ registered studies
- DanicopanExisting use: Acquired paroxysmal nocturnal hemoglobinuria, Hemoglobinuria, Paroxysmal, Hemolysis68.7% AI-predicted activityagainst MRSA30 registered studies
- Simeprevir SodiumExisting use: Chronic hepatitis C virus infection68.6% AI-predicted activityagainst MRSANo documented evidence found
- Lanreotide AcetateExisting use: Acromegaly, Carcinoid syndrome68.3% AI-predicted activityagainst MRSA50+ registered studies
- Cholic AcidExisting use: Abnormality of the gastrointestinal tract, Inborn errors of metabolism, Liver disease and 1 more68.0% AI-predicted activityagainst MRSA50+ registered studies
- EptifibatideExisting use: Acute coronary syndrome, Acute myocardial infarction, Intermediate coronary syndrome and 2 more67.8% AI-predicted activityagainst MRSA35 registered studies
- AbarelixExisting use: Neoplasm67.7% AI-predicted activityagainst MRSA5 registered studies
- EverolimusExisting use: Adenoma sebaceum, Anaplastic astrocytoma, Angiomyolipoma and 18 more67.5% AI-predicted activityagainst MRSA50+ registered studies
- Paliperidone PalmitateExisting use: Mental or behavioural disorder, Psychosis, Schizoaffective disorder and 1 more67.3% AI-predicted activityagainst MRSA50+ registered studies
- PaliperidoneExisting use: Mental or behavioural disorder, Psychosis, Schizoaffective disorder and 1 more67.2% AI-predicted activityagainst MRSA50+ registered studies
- Ozanimod HydrochlorideExisting use: Multiple sclerosis, Relapsing-remitting multiple sclerosis, Ulcerative colitis66.8% AI-predicted activityagainst MRSA7 registered studies
Every repurposing candidate for MRSA, including those with documented evidence →
Registered studies
A registration describes a study; it does not establish a positive result.
Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities
NCT01302210 · start 2010-10
Registered record
- Registry ID
- NCT01302210
- Conditions
- Methicillin Resistant Staphylococcus Aureus
- Interventions
- Decolonization
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2010-10
- Completion
- 2014-11
- Enrolment
- 22,302
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMethicillin Resistant Staphylococcus AureusInterventionDecolonizationPhaseNot recordedRegistry statusCompletedEffect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections
NCT01152593 · start 2010-07
Registered record
- Registry ID
- NCT01152593
- Conditions
- Surgical Wound Infection; Cesarean Section; Staphylococcus Aureus
- Interventions
- Mupirocin
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2010-07
- Completion
- 2014-12
- Enrolment
- 400
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSurgical Wound Infection; Cesarean Section; Staphylococcus AureusInterventionMupirocinPhaseNot applicableRegistry statusUnknownComprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus (MRSA) in the Outpatient Setting
NCT01232231 · start 2010-07
Registered record
- Registry ID
- NCT01232231
- Conditions
- Methicillin-resistant Staphylococcus Aureus
- Interventions
- pharmacological decolonization treatment; Education
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2010-07
- Completion
- 2012-11
- Enrolment
- 15
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMethicillin-resistant Staphylococcus AureusInterventionpharmacological decolonization treatment; EducationPhaseNot applicableRegistry statusCompletedRisk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus
NCT01141101 · start 2010-06
Registered record
- Registry ID
- NCT01141101
- Conditions
- Methicillin-resistant Staphylococcus Aureus
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2010-06
- Completion
- 2012-06
- Enrolment
- 100
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMethicillin-resistant Staphylococcus AureusInterventionNot recordedPhaseNot recordedRegistry statusCompletedMethicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
NCT01105767 · start 2010-05
Registered record
- Registry ID
- NCT01105767
- Conditions
- Staphylococcus Aureus; MRSA Skin Infections; Staphylococcal Skin Infections
- Interventions
- Chlorhexidine gluconate; Supplemental training, education and hygiene
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2010-05
- Completion
- 2012-01
- Enrolment
- 30,209
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionStaphylococcus Aureus; MRSA Skin Infections; Staphylococcal Skin InfectionsInterventionChlorhexidine gluconate; Supplemental training, education and hygienePhaseNot applicableRegistry statusCompletedRandomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Abscess
NCT01498744 · start 2010-02
Registered record
- Registry ID
- NCT01498744
- Conditions
- Abscess Soft Tissue; Methicillin-resistant Staphylococcus Aureus (MRSA) Infection; Skin Abscess
- Interventions
- Oral Clindamycin
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Terminated
- Start
- 2010-02
- Completion
- 2013-02
- Enrolment
- 53
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAbscess Soft Tissue; Methicillin-resistant Staphylococcus Aureus (MRSA) Infection; Skin AbscessInterventionOral ClindamycinPhaseNot applicableRegistry statusTerminatedEpidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community
NCT00966446 · start 2009-09
Registered record
- Registry ID
- NCT00966446
- Conditions
- MRSA - Methicillin Resistant Staphylococcus Aureus Infection
- Interventions
- Unsupervised Decolonization; Supervised Decolonization
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2009-09
- Completion
- 2014-12
- Enrolment
- 223
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMRSA - Methicillin Resistant Staphylococcus Aureus InfectionInterventionUnsupervised Decolonization; Supervised DecolonizationPhaseNot applicableRegistry statusCompletedCluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
NCT00980980 · start 2009-09
Registered record
- Registry ID
- NCT00980980
- Conditions
- Methicillin-resistant Staphylococcus Aureus
- Interventions
- Chlorhexidine bath and nasal mupirocin
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2009-09
- Completion
- 2011-09
- Enrolment
- 74,256
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMethicillin-resistant Staphylococcus AureusInterventionChlorhexidine bath and nasal mupirocinPhaseNot applicableRegistry statusCompletedClearance of Nasal Staphylococcus Aureus With Triple Antibiotic Ointment
NCT00997139 · start 2009-09
Registered record
- Registry ID
- NCT00997139
- Conditions
- Nasal Carriers of Staphylococcus Aureus
- Interventions
- Neosporin (polymyxin B 5,000units, bacitracin 400 units, neomycin 3.5mg)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2009-09
- Completion
- 2010-11
- Enrolment
- 216
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNasal Carriers of Staphylococcus AureusInterventionNeosporin (polymyxin B 5,000units, bacitracin 400 units, neomycin 3.5mg)PhaseNot applicableRegistry statusCompletedTreatment of Patients Colonized With Methicillin-Resistant Staphylococcus Aureus Prior to Bone and Joint Surgery
NCT00903279 · start 2009-08
Registered record
- Registry ID
- NCT00903279
- Conditions
- Orthopedic Procedures; Methicillin-resistant Staphylococcus Aureus
- Interventions
- Placebo; Altabax (retapamulin)
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Withdrawn
- Start
- 2009-08
- Completion
- 2010-12
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOrthopedic Procedures; Methicillin-resistant Staphylococcus AureusInterventionPlacebo; Altabax (retapamulin)PhasePhase 2Registry statusWithdrawnRifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected Adults
NCT00869518 · start 2009-07
Registered record
- Registry ID
- NCT00869518
- Conditions
- Staphylococcus Aureus; HIV Infections
- Interventions
- rifabutin plus trimethoprim sulfamethoxazole; placebo plus trimethoprim-sulfamethoxazole
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Terminated
- Start
- 2009-07
- Completion
- 2010-12
- Enrolment
- 12
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionStaphylococcus Aureus; HIV InfectionsInterventionrifabutin plus trimethoprim sulfamethoxazole; placebo plus trimethoprim-sulfamethoxazolePhasePhase 2Registry statusTerminatedEfficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization
NCT00856089 · start 2009-05
Registered record
- Registry ID
- NCT00856089
- Conditions
- Methicillin-resistant Staphylococcus Aureus
- Interventions
- Retapamulin
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Withdrawn
- Start
- 2009-05
- Completion
- 2009-10
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMethicillin-resistant Staphylococcus AureusInterventionRetapamulinPhasePhase 4Registry statusWithdrawnClinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)
NCT00790608 · start 2009-01
Registered record
- Registry ID
- NCT00790608
- Conditions
- Skin Ulcers; Methicillin-resistant Staphylococcus Aureus Infection
- Interventions
- Nitric Oxide
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Terminated
- Start
- 2009-01
- Completion
- 2011-08
- Enrolment
- 8
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSkin Ulcers; Methicillin-resistant Staphylococcus Aureus InfectionInterventionNitric OxidePhasePhase 2Registry statusTerminatedPharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery
NCT00701636 · start 2008-07
Registered record
- Registry ID
- NCT00701636
- Conditions
- Late Effects of Surgery; Staphylococcus Aureus; Surgical Site Infection
- Interventions
- daptomycin
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2008-07
- Completion
- 2010-10
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionLate Effects of Surgery; Staphylococcus Aureus; Surgical Site InfectionInterventiondaptomycinPhasePhase 3Registry statusCompletedStaphylococcus Aureus Decolonization Study
NCT00731783 · start 2008-07
Registered record
- Registry ID
- NCT00731783
- Conditions
- Staphylococcal Skin Infections; Abscesses; Furunculosis; Staphylococcus Aureus; MRSA Infection
- Interventions
- 2% Mupirocin Ointment; 4% Chlorhexidine liquid soap; Hygiene protocol
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2008-07
- Completion
- 2010-12
- Enrolment
- 183
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionStaphylococcal Skin Infections; Abscesses; Furunculosis; Staphylococcus Aureus +1 moreIntervention2% Mupirocin Ointment; 4% Chlorhexidine liquid soap; Hygiene protocolPhaseNot applicableRegistry statusCompleted